{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F78e651db-a753-4daf-8aa5-58fd07f4f12f","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"","title":"Understanding the Benefit-Risk Determinations of FDA's Latest Guidance Documents","description":"If you haven\u2019t realized it yet, risk management in the medical device industry isn\u2019t going away. How do you navigate, capture, and document when and what to do? \n\nIn this episode, Jon Speer invites guest Mike Drues of Vascular Sciences to join the show as the two discuss FDA\u2019s two, new guidance documents that provide additional transparency, consistency, and objectivity regarding benefit-risk determinations.\n\nSome of the highlights of the show include:\n \n\u25cf\tDifferences between Documents: Under what circumstances that pose a greater risk are acceptable for product submissions vs. appendices related to ISO 14971.\n\u25cf\tNew nine-page benefit-risk assessment worksheet is oversimplified and presents a non-traditional instead of analytical approach to determining benefit-risk.\n\u25cf\tNew guidance documents don\u2019t mention 510(k) device, but why? People should already know about uncertainty and risk of 510(k) medical devices via predicates.\n\u25cf\tHigher risk is acceptable in various classifications of medical devices, including PMAs and BDPs, and when dealing with small populations.\n\u25cf\tAdding to the complexity of medical devices, the guidance documents now include low-, medium-, and high-risk categories and criteria of uncertainty. \n\u25cf\tPay attention to patient\u2019s perspective of uncertainty when available. Are patients willing to truly accept risks and uncertainty to achieve unmet clinical need?\n\u25cf\tMitigate uncertainty in other ways, such as through labeling, degree of need, and clinical evidence/market data of product.\n\u25cf\tProbable Benefit of HDE: Efficacy at a lower statistical power may diminish uncertainty due to giving patients early access to a medical device.","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/56fc1153-bc2d-4ecd-b173-213eedc0f636/4071ce9e-46c7-491d-be7c-716a4108c059.jpg"}